Vetter and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow microneedle drug and vaccine delivery system, have entered into a strategic drug delivery agreement.  Microneedles are a novel technology that can offer advantages as an alternative to traditional needle injections and other routes of administration, mainly in reducing the injectable dose needed to trigger an immune response and accelerating drug absorption by the body.   The companies will leve...